Scientists find molecular switch that allows melanoma to resist therapy
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanomathe deadliest form of skin cancerat some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies. To do this, Ronai's laboratory has been studying a protein named Activating Transcription Factor 2 (ATF2), which is associated with poor prognosis in melanoma....
Source: PhysOrg - Thursday, 2 February
Related articles:
- Less than a week ago
- 2Vote! Reversible doping: Hydrogen flips switch on vanadium oxide
PhysOrg - 4 days ago
- 7Vote! Phase I clinical trial shows drug shrinks melanoma brain metastases
e! Science News - 5 days ago
- Older News
- 5Vote! Scientists study serious immune malfunction
LabSpaces - 7 days ago
- 5Vote! New technique used to discover new viruses in poultry
- 1Vote! New under the sun: Recurrent genetic mutations in melanoma
- 4Vote! Scientists unlock mystery of how molecular 'handedness' arises
- 5Vote! Scientists solve a mystery of bacterial growth and resistance
- 4Vote! Using 'proton grease' to spin-up a molecular rotor
- 5Vote! Mayo Clinic researchers building melanoma vaccine to combat skin cancer
- 5Vote! Researchers building melanoma vaccine to combat skin cancer
- 7Vote! Shock Therapy's Mystery Closer to Being Solved
Yahoo Science News - Monday, 19 March
- 6Vote! New insight into mechanisms behind autoimmune diseases suggests a potential therapy
- 3Vote! In DNA, ‘R-loops’ flip the switch on genes
Futurity.org - Friday, 9 March
- 8Vote! Scientists develop gene therapy approach to grow blood vessels in ischemic limbs
- 9Vote! Vitamin A may slash melanoma risk
- 12Vote! Vitamin A May Slash Melanoma Risk, Especially in Women
(LiveScience.com)
- 12Vote! Newly approved drug for metastatic melanoma nearly doubles median survival
- 9Vote! A unique on-off switch for hormone production
- 9Vote! New melanoma drug Zelboraf nearly doubles survival in majority of patients
- 14Vote! A surprising molecular switch
